Immix Biopharma IMMX
NASDAQ IMMX
$8.15 -0.20 (-2.40%)
At close: Oct 23, 2026 · 4:00 PM EDT

Immix Biopharma (IMMX) Amortization of Deferred Charges (2021 - 2026)

Updated

Analysis

Immix Biopharma (IMMX) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Immix Biopharma 521.01 Mn 288.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39,891.00
Mar 31, 2026 39,189.00
Dec 31, 2025 38,517.00
Sep 30, 2025 37,869.00
Jun 30, 2025 21,341.00
Mar 31, 2025 21,027.00
Dec 31, 2024 20,734.00
Sep 30, 2024 20,457.00
Jun 30, 2024 20,416.00
Mar 31, 2024 20,840.00
Dec 31, 2021 16,619.00
Sep 30, 2021 20,121.00
Jun 30, 2021 19,726.00
Mar 31, 2021 1,691.00
API Access

Immix Biopharma Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=IMMX&period=max&api_key=YOUR_API_KEY